FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/06/043602 [Registered on: 30/06/2022] Trial Registered Prospectively
Last Modified On: 29/06/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Diagnostic 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Shukra vardhana effect of shivlingi beej powder in kshina shukra or Oligospermia 
Scientific Title of Study   Evaluation of shukra-vardhana effect of shivalingi beej(Bryonia laciniosa L.) in the management of kshina- shukra or oligospermia in adult Males : A randomised double arm double blinded placebo control clinical trial. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Himanshu Gautam 
Designation  PG Scholar 
Affiliation  All india institute of ayurveda 
Address  Department of dravyaguna All India Institute of Ayurveda (AIIA) Mathura Road Gautam Puri Sarita Vihar Delhi 110076
Department of dravyaguna All India Institute of Ayurveda (AIIA) Mathura Road Gautam Puri Sarita Vihar Delhi 110076
South
DELHI
110076
India 
Phone  8700769866  
Fax    
Email  hglovesu16@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Bhargav Bhide  
Designation  Assistant Professor 
Affiliation  All India Institute of Ayurveda  
Address  Department of dravyaguna All India Institute of Ayurveda (AIIA) Mathura Road Gautam Puri Sarita Vihar Delhi 110076

South
DELHI
110076
India 
Phone  9372308023  
Fax    
Email  bhargava.183@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Bhargav Bhide 
Designation  Assistant Professor 
Affiliation  All India Institute of Ayurveda  
Address  Department of dravyaguna All India Institute of Ayurveda (AIIA) Mathura Road Gautam Puri Sarita Vihar Delhi 110076

South
DELHI
110076
India 
Phone  9372308023  
Fax    
Email  bhargava.183@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda 
 
Primary Sponsor  
Name  All India Institute Of Ayurveda 
Address  All India Institute Of Ayurveda Sarita Vihar,Gautam puri,New delhi 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
dr Himanshu gautam  All india institute of ayurveda  Opd no 1,2,3 ground floor, hospital block All india institute of ayurveda Department of dravya guna gautampuri, Sarita vihar, New Delhi 110076
South
DELHI 
8700769866

hglovesu16@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
All India Institute Of Ayurveda  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N461||Oligospermia. Ayurveda Condition: Kshina-shukra, (2) ICD-10 Condition:N461||Oligospermia. Ayurveda Condition: KLAIBYAM,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugOther than Classical(1) Medicine Name: Starch powder, Reference: NA, Route: Oral, Dosage Form: Capsules, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -water), Additional Information: -
2Intervention ArmDrugClassical(1) Medicine Name: Shivalingi beej , Reference: Bhavprakash samhita , Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Abhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -water), Additional Information: -
 
Inclusion Criteria  
Age From  30.00 Year(s)
Age To  50.00 Year(s)
Gender  Male 
Details  1. Sperm count below 15 million/ml
2. Patient with clinical presentation of kshina-shukra mentioned in classics i.e, Daurbalya, panduta,sadana shrama, klaibya, maithuna ashakti, chiraat praseka, shukra avisarga, medhra-vrishana vedanaa 
 
ExclusionCriteria 
Details  1. Sperm count > 15million/ml
2. Patient of azoospermia and aspermia
3. patients suffering from varicocele, accessory sex gland infection, sexually transmitted diseases, severe systemic diseases etc. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Improvement in the total sperm count more than 15 million per ml  45 days 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in symptoms of kshina-shukra & other seminal parameters with crf  45 days 
 
Target Sample Size   Total Sample Size="66"
Sample Size from India="66" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/07/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Sexual health is an important aspect of every individual. Problems related to sexual health remain serious issue, particularly in young adults Infertility affects an estimated 15% of couples globally, amounting to 4KS million couples. The calculated global data shows that the percentage of infertility that is attributable to males ranged between 20.20%, and that the percentage of infertile men ranged from 2-5% to 12%, WHO estimate the overall prevalence of primary infertility in India is between 3,9 to 16.8 Indian states prevalence of infertility varies from state to suite such a 37 per cent in Uttar Pradesh, Himachal Pradesh and Maharashtra, so per cent in Andhra Pradesh and 15 per com in Kashmir and prevalence varies in same region across

tribes and caste.


There is a regional variation in the prevalence of anospermia and oligozoospermia in the male partners of infertile couples from different reations of India. The prevalence of azospermia is extremely high in Kurnool and lodhpur (38.3% and 37.4%, respectively). There is also a regional variation in the prevalence of oligozoospermia (31%) in Kurnool


Ayurvedic classics have mentioned that the reproduction is the work of Shidra dhatu, kahina shikra is one of the eight types of Shukradhushti mentioned in the classics. Various drugs have been mentioned in Aurveda classics which act on Kshina-shukru. The drug Shivalingi is mentioned in raj nighantu as rasayani and sarv-siddhikara. The reference of Shivalingi found in In Bhavprakash Samhita for vandhyarva chikitsa as the seeds of Shivalingi are taken with milk which provide male progeny to pregnant mother. Shivalingi belongs to group of valuable drugs in the area of therapeutics of sterility and infertility disorders.


In modern medicines the conditions associated with Kshina-Shukra in ayurveda can be well matched with Oilgospermia. In this condition the sperm count comes below 15 milli/ml." According to ethnomedicinal review Shivalingi have aphrodisiac and -spermatogenic effect. The drug selected for this work is Shivalingi Beej (Bryonia laciniosa L.) and the drug is already evaluated for its Physicochemical, phytochemical study and pre-clinical study but the clinical study has not been conducted yet.


Considering this, present study has been undertaken to evaluate the Shukra vardhan Efecct of Shivalingi Beej


 
Close